Graziano M P, Moxham C P, Malbon C C
J Biol Chem. 1985 Jun 25;260(12):7665-74.
The mammalian beta 2-adrenergic receptor from rat liver has been purified by sequential cycles of affinity chromatography followed by steric exclusion high performance liquid chromatography. In purified preparations, the overall yield of receptor approaches 10%. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of highly purified receptor preparations reveals a single peptide, Mr = 67,000, as judged by silver staining. Purified beta 2-adrenergic receptor migrates on steric-exclusion high performance liquid chromatography in two peaks, Mr = 140,000 and 67,000. Specific binding of (-)-[3H]dihydroalprenolol and (-)-[125I]iodocyanopindolol to purified rat liver beta-adrenergic receptor preparations is stereoselective and displays a rank order of potencies characteristic of a beta 2-adrenergic receptor. The mammalian beta 1-adrenergic receptor of rat fat cells has also been purified (Cubero, A., and Malbon, C.C. (1984) J. Biol. Chem. 259, 1344-1350). When purified in the presence of protease inhibitors, radioiodinated beta 1-adrenergic receptors from rat fat cells and beta 2-adrenergic receptors from rat liver comigrate on sodium dodecyl sulfate-polyacrylamide gels as 67,000 Mr peptides. Autoradiograms of two-dimensional partial proteolytic digests of the purified, radioiodinated rat liver beta-adrenergic receptor, as generated by alpha-chymotrypsin, Staphylococcus aureus V8 protease, and elastase reveal a pattern of peptide fragments essentially identical to those generated by partial proteolytic digests of the purified radioiodinated beta 1-receptor from rat fat cells. This data suggests that a high degree of homology exists between these two pharmacologically distinct mammalian beta-adrenergic receptor proteins.
大鼠肝脏的哺乳动物β2 - 肾上腺素能受体通过亲和层析和空间排阻高效液相色谱的连续循环进行纯化。在纯化制剂中,受体的总产率接近10%。通过银染判断,高度纯化的受体制剂的十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳显示出一条单一肽带,Mr = 67,000。纯化的β2 - 肾上腺素能受体在空间排阻高效液相色谱上以两个峰迁移,Mr分别为140,000和67,000。(-)-[3H]二氢阿普洛尔和(-)-[125I]碘氰吲哚洛尔与纯化的大鼠肝脏β - 肾上腺素能受体制剂的特异性结合具有立体选择性,并显示出β2 - 肾上腺素能受体特有的效价顺序。大鼠脂肪细胞的哺乳动物β1 - 肾上腺素能受体也已被纯化(Cubero, A., 和Malbon, C.C. (1984) J. Biol. Chem. 259, 1344 - 1350)。当在蛋白酶抑制剂存在下纯化时,来自大鼠脂肪细胞的放射性碘化β1 - 肾上腺素能受体和来自大鼠肝脏 的β2 - 肾上腺素能受体在十二烷基硫酸钠 - 聚丙烯酰胺凝胶上作为Mr = 67,000的肽段共同迁移。由α - 胰凝乳蛋白酶、金黄色葡萄球菌V8蛋白酶和弹性蛋白酶产生的纯化的放射性碘化大鼠肝脏β - 肾上腺素能受体的二维部分蛋白水解消化的放射自显影片显示,肽片段模式与来自大鼠脂肪细胞的纯化的放射性碘化β1 - 受体的部分蛋白水解消化产生的模式基本相同。该数据表明这两种药理学上不同的哺乳动物β - 肾上腺素能受体蛋白之间存在高度同源性。